Wormwood for Joint Pain: What the Human Trial Evidence Shows
One randomized trial tested topical 3% wormwood ointment against piroxicam gel in knee osteoarthritis. What it found, and where the evidence stops.
One randomized trial tested topical 3% wormwood ointment against piroxicam gel in knee osteoarthritis. What it found, and where the evidence stops.
What human evidence exists for wormwood in SIBO, why the herbal-vs-rifaximin trial does not prove it works, and the safety tradeoffs of long use.
The black walnut, wormwood and clove protocol from the 1993 Hulda Clark book: what it involves, what the evidence shows, and the safety issues.
Compare wildcrafted and cultivated Artemisia absinthium: growing conditions, phytochemical profiles, thujone variability, and quality markers for sourcing.
Wormwood and mugwort are different Artemisia species with different chemistry, different uses, and a documented history of being confused for each other.
Comparing wormwood, gentian, and dandelion as digestive bitters: traditional uses, proposed mechanisms, safety profiles, and evidence gaps.
Compare wormwood and black walnut for parasite cleanses: traditional uses, proposed mechanisms, safety profiles, and evidence gaps.
Historical review of wormwood’s traditional European applications for digestion, parasites, and fevers, with safety context on thujone content.
A 10-patient uncontrolled trial reported a large drop in proteinuria in IgA nephropathy. A 2024 case report describes acute kidney injury. Both are small.
Evidence-based review of wormwood safety concerns including thujone neurotoxicity, pregnancy contraindications, and cytochrome P450-mediated drug interactions.
Wormwood (Artemisia absinthium) is contraindicated in pregnancy and breastfeeding due to thujone neurotoxicity and uterine-stimulating effects.
Published wormwood poisoning cases include an infant with metabolic acidosis, a man with measured serum thujone, and a teenager with acute kidney injury.